#Stocks
目前不在新聞媒體排行榜上。
每小時新聞數量與 24 小時移動平均（固定基準 110 家媒體）怎麼算 ⓘ
過去 3 天標成 #Stocks 的報導
另有 8 篇標題或摘要提到「Stocks」，但沒有這個標籤。看所有提到「Stocks」的文章 →
10/7（三）
Hong Kong tech index to harness fast-growth firms for perfo…
Hong Kong’s stock index compiler will add 10 fast-growing companies with at least HK$500 million (US$64 million) in annual sales into the city’s technology-focused benchmark in a bid to revitalise an index that has missed out on artificial intelligence-driven gains. The threshold is among a set of new measures Hang Seng Indexes Company will use to reform the Hang Seng Tech Index, which is referred to as Hong Kong’s answer to the Nasdaq but has lost its shine relative to global peers, falling 23...
#Hong Kong stock market#China#Hong Kong#Hang Seng Bank#Stocks#Hang Seng Index
Asian investors turn to real estate as global tension shake…
Amid various macro uncertainties, interest in private credit declined sharply to 48 per cent from 71 – among alternative investments – while interest in real estate jumped to 52 from 39 per cent, according to the 2026 Asia Advisor Survey released today by financial technology company iCapital. This marks a 23 per cent decline for private credit, which was the leading area of interest among Asian advisers in 2025. In addition to real estate, advisers are also turning to other real assets, with...
#Banking & finance#China#Property investment#Hong Kong#Stocks#China stock market
Chinese biotech faces reality check as ArriVent drug failur…
US firm ArriVent BioPharma’s shares plummeted after a late-stage trial failure involving a cancer drug licensed from China, a setback that analysts said highlighted the challenges facing Chinese biotech companies expanding overseas. New York-listed ArriVent closed down nearly 47 per cent on Tuesday after reporting that its cancer treatment firmonertinib failed to meet its main goal in a phase 3 trial. Firmonertinib was originally developed by Shanghai Allist Pharmaceuticals to treat non-small...
#Biomedicine: Companies#Stocks#Cancer#Biomedicine: Industry Trends#Drugs#Medicine
南華早報10/6（二）
Transsion, Africa’s top phone maker, targets US$500 million…
Shenzhen Transsion Holdings, the maker of Africa’s bestselling phones, aims to kick off its Hong Kong share offering on Wednesday to raise up to US$500 million ahead of a targeted October 15 listing, according to people familiar with the matter. The company, which already trades in Shanghai and has a market capitalisation of 62 billion yuan (US$9.24 billion), could offer up to 132 million offshore ordinary shares, according to approval documents from the China Securities Regulatory Commission...
#IPO#Hong Kong stock market#Banking & finance#Smartphones#Stocks#Hong Kong
